AZTAAzenta, Inc.
- Market cap
- $1.60B
- as of 2026-10-23
- Latest close
- $36.50
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Medical Instruments & Supplies
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-17
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Madaus Martin DInterim CEO | Oct 22 | Oct 23 | F | 1,294 | $36.01 | $46,597 | 41,308 | Not reported | Form 4 |
| Madaus Martin DInterim CEO | Sep 22 | Sep 23 | F | 1,456 | $34.28 | $49,912 | 42,602 | No | Form 4 |
| Bello Erik J.VP Chief Accounting Officer | Sep 15 | Sep 16 | A | 4,586 | $0.00 | $0 | 4,586 | No | Form 4 |
| Starr EphraimSVP, Gen Counsel & Secretary | Sep 14 | Sep 16 | A | 15,272 | $0.00 | $0 | 84,000 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Sep 14 | Sep 16 | A | 30,544 | $0.00 | $0 | 110,199 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Sep 14 | Sep 16 | A | 15,272 | $0.00 | $0 | 47,225 | No | Form 4 |
| Martin William E. IIIPresident Multiomics | Sep 14 | Sep 16 | A | 15,272 | $0.00 | $0 | 33,062 | No | Form 4 |
| Madaus Martin DInterim CEO | Sep 14 | Sep 16 | A | 36,653 | $0.00 | $0 | 44,058 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Aug 9 | Aug 11 | F | 1,085 | $32.04 | $34,763 | 31,953 | No | Form 4 |
| Starr EphraimSVP, Gen Counsel & Secretary | Jul 31 | Aug 4 | P | 335 | $24.17 | Purchase +$8,097 | 68,728 | No | Form 4 |
| Cornog William L | May 18 | May 19 | P | 10,000 | $16.38 | Purchase +$163,800 | 19,703 | No | Form 4 |
| Starr EphraimSVP, Gen Counsel & Secretary | May 15 | May 18 | F | 3,621 | $16.02 | $58,008 | 68,393 | No | Form 4 |
| Koffey Quentin | Feb 5 | May 12 | A | 5,663 | $0.00 | $0 | 10,698 | No | Form 4 |
| Martin William E. IIIPresident Multiomics | Apr 28 | Apr 30 | A | 17,790 | $24.24 | $431,230 | 17,790 | No | Form 4 |
| Nova Tina Susan | Feb 6 | Feb 6 | A | 5,663 | $27.85 | $157,715 | 15,772 | No | Form 4 |
| Davis Robyn C | Feb 5 | Feb 6 | A · derivative | 5,663 | not reported | not reported | 23,662 | No | Form 4 |
| McLaughlin Erica | Feb 5 | Feb 6 | A | 5,663 | $27.85 | $157,715 | 22,521 | No | Form 4 |
| Casal Frank | Feb 5 | Feb 6 | A | 7,243 | $27.85 | $201,718 | 21,803 | No | Form 4 |
| Doshi Dipal | Feb 5 | Feb 6 | A | 5,663 | $27.85 | $157,715 | 9,703 | No | Form 4 |
| Madaus Martin D | Feb 5 | Feb 6 | A · derivative | 5,663 | not reported | not reported | 9,703 | No | Form 4 |
| Marotta JohnPresident and CEO | Nov 24, 2025 | Dec 3, 20254/A | A | 118,194 | $0.00 | $0 | 213,193.78 | No | Form 4/A |
| Starr EphraimSVP, Gen Counsel & Secretary | Nov 24, 2025 | Nov 25, 2025 | A | 34,235 | $0.00 | $0 | 72,014 | No | Form 4 |
| Zhou GingerSVP and GM, Multiomics | Nov 24, 2025 | Nov 25, 2025 | A | 13,042 | $0.00 | $0 | 38,755 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Nov 24, 2025 | Nov 25, 2025 | A | 16,303 | $0.00 | $0 | 33,038 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Nov 24, 2025 | Nov 25, 2025 | A | 36,681 | $0.00 | $0 | 79,655 | No | Form 4 |
| Cornog William L | May 20, 2025 | Nov 25, 20254/A | P | 2,748 | $27.37 | Purchase +$75,213 | 25,795 | No | Form 4/A |
| Cornog William L | May 19, 2025 | Nov 25, 20254/A | P | 4,152 | $26.98 | Purchase +$112,021 | 23,047 | No | Form 4/A |
| Cornog William L | May 16, 2025 | Nov 25, 20254/A | P | 100 | $26.50 | Purchase +$2,650 | 18,895 | No | Form 4/A |
| Marotta JohnPresident and CEO | Nov 14, 2025 | Nov 17, 2025 | F | 10,980 | $29.75 | $326,655 | 94,999.78 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Nov 14, 2025 | Nov 17, 2025 | F | 3,039 | $29.75 | $90,410 | 42,974 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Nov 14, 2025 | Nov 17, 2025 | F | 1,553 | $29.75 | $46,202 | 16,735 | No | Form 4 |
| Zhou GingerSVP and GM, Multiomics | Nov 14, 2025 | Nov 17, 2025 | F | 1,118 | $29.75 | $33,261 | 25,713 | No | Form 4 |
| Zhou GingerSVP and GM, Multiomics | Aug 12, 2025 | Nov 14, 20254/A | S | 1,085 | $28.54 | Sale −$30,966 | 26,831 | No | Form 4/A |
| Pirogova OlgaSVP and CHRO | Aug 12, 2025 | Nov 14, 20254/A | S | 1,085 | $28.54 | Sale −$30,966 | 18,288 | No | Form 4/A |
| Marotta JohnPresident and CEO | Jun 2, 2025 | Nov 14, 20254/A | P | 1,000 | $25.99 | Purchase +$25,990 | 107,295.78 | No | Form 4/A |
| Malus Alan J | May 30, 2025 | Nov 14, 20254/A | P | 12,000 | $26.65 | Purchase +$319,800 | 17,035 | No | Form 4/A |
| Marotta JohnPresident and CEO | Sep 10, 2025 | Sep 12, 2025 | S | 316 | $29.41 | Sale −$9,294 | 105,979.78 | No | Form 4 |
| Marotta JohnPresident and CEO | Jun 2, 2025 | Jun 4, 2025 | A | 1,000 | $25.99 | $25,990 | 107,295.78 | No | Form 4 |
| Marotta JohnPresident and CEO | May 9, 2025 | Jun 4, 20254/A | A | 1,796.17 | $27.49 | $49,377 | 106,295.78 | No | Form 4/A |
| Marotta JohnPresident and CEO | May 8, 2025 | Jun 4, 20254/A | A | 3,637.64 | $27.49 | $99,999 | 104,499.62 | No | Form 4/A |
| Starr EphraimSVP, Gen Counsel & Secretary | May 15, 2025 | May 27, 2025 | A | 37,779 | $26.71 | $1,009,077 | 37,779 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | May 9, 2025 | May 12, 2025 | A | 4,000 | $27.49 | $109,960 | 43,513 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | May 8, 2025 | May 12, 2025 | A | 2,000 | $27.67 | $55,340 | 39,513 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Feb 11, 2025 | Feb 13, 2025 | A | 2,200 | $46.00 | $101,200 | 37,513 | No | Form 4 |
| McLaughlin Erica | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $52.32 | $211,373 | 16,858 | No | Form 4 |
| Doshi Dipal | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $52.32 | $211,373 | 4,040 | No | Form 4 |
| Nova Tina Susan | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $52.32 | $211,373 | 10,109 | No | Form 4 |
| Davis Robyn C | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $52.32 | $211,373 | 33,627 | No | Form 4 |
| Casal Frank | Feb 7, 2025 | Feb 11, 2025 | A | 5,168 | $52.32 | $270,390 | 14,560 | No | Form 4 |
| Malus Alan J | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $52.32 | $211,373 | 5,035 | No | Form 4 |
| Cornog William L | Feb 7, 2025 | Feb 11, 2025 | A · derivative | 4,040 | not reported | not reported | 4,040 | No | Form 4 |
| Koffey Quentin | Feb 7, 2025 | Feb 11, 2025 | A | 4,040 | $0.00 | $0 | 5,035 | No | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | Feb 3, 2025 | Feb 4, 2025 | S | 317 | $52.97 | Sale −$16,791 | 9,603 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Jan 31, 2025 | Feb 4, 2025 | P | 417 | $45.88 | Purchase +$19,132 | 27,916 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Dec 5, 2024 | Dec 9, 2024 | A | 23,045 | $45.00 | $1,037,025 | 29,545 | No | Form 4 |
| Lin Lawrence Y.EVP, CFO and Treasurer | Dec 5, 2024 | Dec 9, 2024 | A | 5,768 | $45.00 | $259,560 | 35,313 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Dec 4, 2024 | Dec 5, 2024 | D | 140 | $46.65 | $6,531 | 23,974 | No | Form 4 |
| Cueto HermanEVP, Chief Financial Officer | Nov 19, 2024 | Nov 21, 2024 | S | 712 | $40.07 | Sale −$28,530 | 23,892 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Nov 19, 2024 | Nov 21, 2024 | S | 1,139 | $40.07 | Sale −$45,640 | 112,564 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Nov 19, 2024 | Nov 21, 2024 | S | 348 | $40.07 | Sale −$13,944 | 24,114 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Nov 19, 2024 | Nov 21, 2024 | S | 491 | $40.07 | Sale −$19,674 | 27,499 | No | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | Nov 19, 2024 | Nov 21, 2024 | S | 163 | $40.07 | Sale −$6,531 | 9,920 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Nov 19, 2024 | Nov 21, 2024 | S | 548 | $40.07 | Sale −$21,958 | 19,373 | No | Form 4 |
| Madaus Martin D | Nov 19, 2024 | Nov 19, 2024 | P | 4,940 | $40.77 | Purchase +$201,404 | 7,405 | No | Form 4 |
| Marotta JohnPresident and CEO | Nov 19, 2024 | Nov 19, 2024 | P | 1,250 | $40.67 | Purchase +$50,838 | 100,861.98 | No | Form 4 |
| Cornog William L | Nov 18, 2024 | Nov 19, 2024 | P | 12,500 | $39.60 | Purchase +$495,000 | 14,755 | No | Form 4 |
| Hirsch Didier | Nov 18, 2024 | Nov 19, 2024 | P | 1,000 | $39.50 | Purchase +$39,500 | 3,465 | No | Form 4 |
| Marotta JohnPresident and CEO | Nov 18, 2024 | Nov 19, 2024 | P | 12,716.98 | $39.48 | Purchase +$502,066 | 99,611.98 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Nov 15, 2024 | Nov 19, 2024 | A | 8,651 | $41.51 | $359,103 | 27,990 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Nov 15, 2024 | Nov 19, 2024 | A | 8,651 | $41.51 | $359,103 | 24,462 | No | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | Nov 15, 2024 | Nov 19, 2024 | A | 6,921 | $41.51 | $287,291 | 10,083 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Nov 15, 2024 | Nov 19, 2024 | A | 13,841 | $41.51 | $574,540 | 113,703 | No | Form 4 |
| Marotta JohnPresident and CEO | Nov 15, 2024 | Nov 19, 2024 | A | 83,622 | $41.51 | $3,471,149 | 86,895 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Nov 15, 2024 | Nov 19, 2024 | A | 10,381 | $41.51 | $430,915 | 19,921 | No | Form 4 |
| Malus Alan J | Nov 6, 2024 | Nov 14, 2024 | D | 995 | $46.52 | $46,287 | 995 | No | Form 4 |
| Cornog William L | Nov 6, 2024 | Nov 8, 2024 | D | 995 | $46.52 | $46,287 | 2,255 | No | Form 4 |
| Koffey Quentin | Nov 6, 2024 | Nov 8, 2024 | A | 995 | $0.00 | $0 | 995 | No | Form 4 |
| Cueto HermanEVP, Chief Financial Officer | Oct 17, 2024 | Oct 21, 2024 | S | 1,595 | $43.68 | Sale −$69,670 | 24,604 | No | Form 4 |
| Marotta JohnPresident and CEO | Sep 9, 2024 | Sep 11, 2024 | A | 3,273 | $46.15 | $151,049 | 3,273 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Aug 9, 2024 | Aug 13, 2024 | A | 6,333 | $55.27 | $350,025 | 19,339 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Aug 9, 2024 | Aug 13, 2024 | A | 10,856 | $55.27 | $600,011 | 99,862 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Aug 9, 2024 | Aug 13, 2024 | A | 6,333 | $55.27 | $350,025 | 9,540 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Aug 9, 2024 | Aug 13, 2024 | A | 6,333 | $55.27 | $350,025 | 15,811 | No | Form 4 |
| Cueto HermanEVP, Chief Financial Officer | Aug 9, 2024 | Aug 13, 2024 | A | 11,309 | $55.27 | $625,048 | 26,199 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Jan 31, 2024 | Aug 2, 2024 | A | 151 | $53.01 | $8,005 | 31,438 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Jan 31, 2024 | Aug 2, 2024 | A | 64 | $53.01 | $3,393 | 13,006 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Aug 1, 2024 | Aug 1, 2024 | D | 1,000 | $62.05 | $62,050 | 89,006 | Yes | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Jul 25, 2024 | Jul 29, 2024 | D | 3,000 | $60.00 | $180,000 | 90,006 | Yes | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | May 20, 2024 | May 22, 2024 | D | 584 | $51.36 | $29,994 | 3,162 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Apr 1, 2024 | Apr 2, 2024 | D | 1,000 | $60.15 | $60,150 | 93,006 | Yes | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Mar 8, 2024 | Mar 11, 2024 | D | 4,000 | $67.50 | $270,000 | 94,006 | Yes | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Mar 7, 2024 | Mar 11, 2024 | D | 1,000 | $65.21 | $65,210 | 106,006 | Yes | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Mar 7, 2024 | Mar 11, 2024 | D | 4,000 | $65.20 | $260,800 | 102,006 | Yes | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Mar 7, 2024 | Mar 11, 2024 | D | 4,000 | $65.00 | $260,000 | 98,006 | Yes | Form 4 |
| Nova Tina Susan | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 6,069 | No | Form 4 |
| McLaughlin Erica | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 12,818 | No | Form 4 |
| Rosenblatt Michael | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 13,042 | No | Form 4 |
| Davis Robyn C | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 29,587 | No | Form 4 |
| Casal Frank | Feb 12, 2024 | Feb 13, 2024 | A | 3,603 | $65.93 | $237,546 | 9,392 | No | Form 4 |
| Hirsch Didier | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 2,465 | No | Form 4 |
| Madaus Martin D | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 2,465 | No | Form 4 |
| Bousa Edward Peter | Feb 12, 2024 | Feb 13, 2024 | A | 2,465 | $65.93 | $162,517 | 2,465 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Feb 1, 2024 | Feb 2, 2024 | A | 324 | $39.41 | $12,769 | 31,287 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Feb 1, 2024 | Feb 2, 2024 | A | 448 | $39.41 | $17,656 | 12,942 | No | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | Jan 31, 2024 | Feb 1, 2024 | A | 311 | $65.20 | $20,277 | 3,746 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Dec 5, 2023 | Dec 6, 2023 | D | 5,175 | $56.60 | $292,905 | 25,788 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Dec 1, 2023 | Dec 5, 2023 | D | 138 | $57.96 | $7,998 | 9,478 | No | Form 4 |
| Gray David CChief Strategy & New Business | Nov 17, 2023 | Nov 20, 2023 | D | 5,179 | $54.83 | $283,965 | 74,868 | No | Form 4 |
| Cueto HermanEVP, Chief Financial Officer | Nov 16, 2023 | Nov 17, 2023 | A | 5,727 | $54.57 | $312,522 | 5,727 | No | Form 4 |
| Cueto HermanEVP, Chief Financial Officer | Nov 16, 2023 | Nov 17, 2023 | A | 9,163 | $54.57 | $500,025 | 14,890 | No | Form 4 |
| Gray David CChief Strategy & New Business | Nov 16, 2023 | Nov 17, 2023 | D | 2,161 | $53.81 | $116,283 | 77,756 | No | Form 4 |
| Gray David CChief Strategy & New Business | Nov 16, 2023 | Nov 17, 2023 | A | 2,291 | $54.57 | $125,020 | 80,047 | No | Form 4 |
| Hughes ViolettaVP, Chief Accounting Officer | Nov 16, 2023 | Nov 17, 2023 | A | 1,374 | $54.57 | $74,979 | 4,057 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Nov 16, 2023 | Nov 17, 2023 | D | 1,831 | $53.81 | $98,526 | 101,508 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Nov 16, 2023 | Nov 17, 2023 | A | 5,498 | $54.57 | $300,026 | 107,006 | No | Form 4 |
| Pirogova OlgaSVP and CHRO | Nov 16, 2023 | Nov 17, 2023 | A | 3,207 | $54.57 | $175,006 | 3,207 | No | Form 4 |
| Robertson Lindon GEVP & Chief Financial Officer | Nov 16, 2023 | Nov 17, 2023 | D | 2,779 | $53.81 | $149,538 | 121,081 | No | Form 4 |
| Schwartz Stephen SCEO | Nov 16, 2023 | Nov 17, 2023 | D | 12,865 | $53.81 | $692,266 | 424,088 | No | Form 4 |
| Schwartz Stephen SCEO | Nov 16, 2023 | Nov 17, 2023 | A | 22,448 | $54.57 | $1,224,987 | 446,536 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Nov 16, 2023 | Nov 17, 2023 | D | 2,946 | $53.81 | $158,524 | 26,381 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Nov 16, 2023 | Nov 17, 2023 | A | 4,582 | $54.57 | $250,040 | 30,963 | No | Form 4 |
| Wang David DongSVP & GM, SMS | Nov 16, 2023 | Nov 17, 2023 | A | 3,207 | $54.57 | $175,006 | 9,616 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Nov 16, 2023 | Nov 17, 2023 | D | 458 | $53.81 | $24,645 | 9,287 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Nov 16, 2023 | Nov 17, 2023 | A | 3,207 | $54.57 | $175,006 | 12,494 | No | Form 4 |
| Gray David CChief Strategy & New Business | Nov 15, 2023 | Nov 17, 2023 | A | 2,875 | $54.13 | $155,624 | 79,917 | No | Form 4 |
| Joseph JasonSVP, General Counsel, Secy. | Nov 15, 2023 | Nov 17, 2023 | A | 3,559 | $54.13 | $192,649 | 103,339 | No | Form 4 |
| Robertson Lindon GEVP & Chief Financial Officer | Nov 15, 2023 | Nov 17, 2023 | A | 6,297 | $54.13 | $340,857 | 123,860 | No | Form 4 |
| Schwartz Stephen SCEO | Nov 15, 2023 | Nov 17, 2023 | A | 16,426 | $54.13 | $889,139 | 436,953 | No | Form 4 |
| Vacha RobinSVP, GM Life Science Products | Nov 15, 2023 | Nov 17, 2023 | A | 4,107 | $54.13 | $222,312 | 29,327 | No | Form 4 |
| Zhou GingerSVP and General Manager, Genom | Nov 15, 2023 | Nov 17, 2023 | A | 877 | $54.13 | $47,472 | 9,745 | No | Form 4 |